Haemostasiologic effects of various glucose-lowering medications in type 2 diabetes mellitus.

被引:0
作者
Petrik, G. G. [1 ]
Pavlishchuk, S. A. [1 ]
机构
[1] Kuban State Med Univ, Krasnodar, Russia
来源
CARDIOVASCULAR THERAPY AND PREVENTION | 2010年 / 9卷 / 02期
关键词
INSULIN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:48 / 53
页数:6
相关论文
共 50 条
[21]   Adverse Effects of Glycemia-Lowering Medications in Type 2 Diabetes [J].
Razavi-Nematollahi, Laleh ;
Ismail-Beigi, Faramarz .
CURRENT DIABETES REPORTS, 2019, 19 (11)
[22]   Progression of glucose-lowering diabetes therapy in TECOS [J].
Bethel, M. Angelyn ;
Engel, Samuel S. ;
Stevens, Susanna R. ;
Lokhnygina, Yuliya ;
Ding, Jie ;
Josse, Robert G. ;
Alvarsson, Michael ;
Hramiak, Irene ;
Green, Jennifer B. ;
Peterson, Eric D. ;
Holman, Rury R. .
ENDOCRINOLOGY DIABETES & METABOLISM, 2019, 2 (01)
[23]   Use of Glucose-Lowering Agents in Diabetes and CKD [J].
Alicic, Radica Z. ;
Neumiller, Joshua J. ;
Galindo, Rodolfo J. ;
Tuttle, Katherine R. .
KIDNEY INTERNATIONAL REPORTS, 2022, 7 (12) :2589-2607
[24]   THE GLUCOSE-LOWERING THERAPY STRUCTURE IN SPECIAL GROUPS OF TYPE 2 DIABETES MELLITUS PATIENTS BASED ON DATA FROM THE MOSCOW REGION REGISTER [J].
Misnikova, Inna, V ;
Kovaleva, Yulia A. ;
Isakov, Mikhail A. ;
Dreval, Alexander, V .
DIABETES MELLITUS, 2019, 22 (03) :206-216
[25]   Insulinization in type 2 diabetes mellitus. Intensification options [J].
Fuente, Graciela V. ;
Sinay, Isaac ;
Costa Gil, Jose E. ;
Puchulu, Felix ;
Dieuzeide, Guillermo ;
Rodriguez, Martin ;
Faingold, Maria C. ;
Litwak, Leon E. .
MEDICINA-BUENOS AIRES, 2016, 76 (03) :173-179
[26]   Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus [J].
Fauchier, Gregoire ;
Bisson, Arnaud ;
Bodin, Alexandre ;
Herbert, Julien ;
Angoulvant, Denis ;
Ducluzeau, Pierre Henri ;
Lip, Gregory Y. H. ;
Fauchier, Laurent .
DIABETOLOGIA, 2021, 64 (11) :2602-2605
[27]   Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus [J].
Gregoire Fauchier ;
Arnaud Bisson ;
Alexandre Bodin ;
Julien Herbert ;
Denis Angoulvant ;
Pierre Henri Ducluzeau ;
Gregory Y. H. Lip ;
Laurent Fauchier .
Diabetologia, 2021, 64 :2602-2605
[28]   Complementary glucagonostatic and insulinotropic effects of DPP-4 inhibitors in the glucose-lowering action in Japanese patients with type 2 diabetes [J].
Hashimoto K.-I. ;
Horikawa Y. ;
Takeda J. .
Diabetology International, 2016, 7 (2) :133-140
[29]   Time to Failure on Oral Glucose-Lowering Agents for Patients with Type 2 Diabetes: A Retrospective Cohort Study [J].
Boye, Kristina S. ;
Lage, Maureen J. ;
Kiljanski, Jacek .
DIABETES THERAPY, 2021, 12 (05) :1463-1474
[30]   Risk of Severe Hypoglycemia With Newer Second-line Glucose-lowering Medications in Older Adults With Type 2 Diabetes Stratified by Known Indicators of Hypoglycemia Risk [J].
Htoo, Phyo T. ;
Paik, Julie M. ;
Alt, Ethan ;
Kim, Dae Hyun ;
Wexler, Deborah J. ;
Kim, Seoyoung C. ;
Patorno, Elisabetta .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2023, 78 (12) :2426-2434